Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype.

Ding YB, Deng B, Huang YS, Xiao WM, Wu J, Zhang YQ, Wang YZ, Wu DC, Lu GT, Wu KY.

Dig Dis Sci. 2013 Jun;58(6):1627-35. doi: 10.1007/s10620-012-2524-6. Epub 2013 Jan 11.

PMID:
23306848
2.

EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.

Hao XY, Cai JP, Liu X, Chen W, Hou X, Chen D, Lai JM, Liang LJ, Yin XY.

Chin J Cancer. 2016 Jul 28;35(1):70. doi: 10.1186/s40880-016-0133-z.

3.

Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.

Zhang C, Liu LX, Dong ZR, Shi GM, Cai JB, Zhang PF, Ke AW, Yu JX, Zhou J, Fan J.

Tumour Biol. 2015 Mar;36(3):1781-9. doi: 10.1007/s13277-014-2780-5. Epub 2014 Nov 13.

PMID:
25391422
4.

High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.

Shi RY, Yang XR, Shen QJ, Yang LX, Xu Y, Qiu SJ, Sun YF, Zhang X, Wang Z, Zhu K, Qin WX, Tang ZY, Fan J, Zhou J.

Cancer. 2013 Mar 1;119(5):993-1003. doi: 10.1002/cncr.27788. Epub 2012 Nov 6.

5.

Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.

Xu Y, Zhu M, Zhang S, Liu H, Li T, Qin C.

Pathol Oncol Res. 2010 Jun;16(2):169-75. doi: 10.1007/s12253-009-9200-y. Epub 2009 Sep 9.

PMID:
19757198
6.

Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.

Zhang C, Bai DS, Huang XY, Shi GM, Ke AW, Yang LX, Yang XR, Zhou J, Fan J.

PLoS One. 2013;8(1):e54619. doi: 10.1371/journal.pone.0054619. Epub 2013 Jan 22.

7.

High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.

Xu YF, Ge FJ, Han B, Yang XQ, Su H, Zhao AC, Zhao MH, Yang YB, Yang J.

World J Gastroenterol. 2015 Mar 21;21(11):3256-65. doi: 10.3748/wjg.v21.i11.3256.

8.

The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.

Wang Y, Wan M, Zhou Q, Wang H, Wang Z, Zhong X, Zhang L, Tai S, Cui Y.

PLoS One. 2015 Oct 20;10(10):e0141165. doi: 10.1371/journal.pone.0141165. eCollection 2015.

9.

SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.

Zhao Z, Ma J, Wu K, Chen L, Yu J, Hu W, Zhang K.

Clin Transl Oncol. 2016 Sep;18(9):878-83. doi: 10.1007/s12094-015-1449-x. Epub 2015 Nov 13.

PMID:
26563145
10.

Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.

Huang XY, Zhang C, Cai JB, Shi GM, Ke AW, Dong ZR, Zhang PF, Fan J, Peng BG, Zhou J.

PLoS One. 2014 May 9;9(5):e96860. doi: 10.1371/journal.pone.0096860. eCollection 2014.

11.

Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.

Nakagawa S, Okabe H, Sakamoto Y, Hayashi H, Hashimoto D, Yokoyama N, Sakamoto K, Kuroki H, Mima K, Nitta H, Imai K, Chikamoto A, Watanabe M, Beppu T, Baba H.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S667-75. doi: 10.1245/s10434-013-3135-y. Epub 2013 Jul 26.

PMID:
23887863
12.

High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.

Jin J, Ryu HS, Lee KB, Jang JJ.

PLoS One. 2014 Feb 28;9(2):e90247. doi: 10.1371/journal.pone.0090247. eCollection 2014.

13.

Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.

Bergeat D, Fautrel A, Turlin B, Merdrignac A, Rayar M, Boudjema K, Coulouarn C, Sulpice L.

J Surg Res. 2016 Jun 15;203(2):441-50. doi: 10.1016/j.jss.2016.03.044. Epub 2016 Mar 26.

PMID:
27363654
14.

Downregulation of ROS-FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells.

Deng G, Hu C, Zhu L, Huang F, Huang W, Xu H, Nie W.

Int J Mol Med. 2014 Sep;34(3):661-8. doi: 10.3892/ijmm.2014.1823. Epub 2014 Jun 27.

15.

Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.

Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M.

Hum Pathol. 2007 Dec;38(12):1819-25. Epub 2007 Sep 14.

PMID:
17854859
16.

Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.

Wu SY, Yu MX, Li XG, Xu SF, Shen J, Sun Z, Zhou X, Chen XZ, Tu JC.

Asian Pac J Cancer Prev. 2014;15(7):3299-304.

17.

Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells.

Okamoto K, Tajima H, Ohta T, Nakanuma S, Hayashi H, Nakagawara H, Onishi I, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Tani T, Fujimura T, Kayahara M, Harada S, Wakayama T, Iseki S.

Int J Oncol. 2010 Nov;37(5):1251-9.

PMID:
20878072
18.

Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.

Xiong GP, Zhang JX, Gu SP, Wu YB, Liu JF.

Neoplasma. 2012;59(4):409-15. doi: 10.4149/neo_2012_053.

PMID:
22489696
19.

Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma.

Terashi T, Aishima S, Taguchi K, Asayama Y, Sugimachi K, Matsuura S, Shimada M, Maehara S, Maehara Y, Tsuneyoshi M.

Liver Int. 2004 Feb;24(1):38-45.

PMID:
15101999
20.

MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.

Huang Q, Liu L, Liu CH, You H, Shao F, Xie F, Lin XS, Hu SY, Zhang CH.

Asian Pac J Cancer Prev. 2013;14(2):829-34.

Supplemental Content

Support Center